WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Jazz Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mary Elizabeth HendersonSVP Technical Operations2025-12-092,238$169.51
$379.37kSell
Patricia CarrSVP Chief Accounting Officer2025-12-054,500$140.67
$633.02kBuy
Renee D. GalaPresident CEO2025-12-0580$166.91
$13.35kSell
Patricia CarrSVP Chief Accounting Officer2025-12-054,500$171.20
$770.40kSell
Patricia CarrSVP Chief Accounting Officer2025-12-05160$171.11
$27.38kSell
Kenneth W. OkeefeDirector2025-12-02603$173.07
$104.36kSell
Bruce C. CozaddDirector2025-11-2638,126$177.27
$6.76MSell
Bruce C. CozaddDirector2025-11-26507$179.79
$91.15kSell
Bruce C. CozaddDirector2025-11-268,380$179.23
$1.50MSell
Bruce C. CozaddDirector2025-11-2630,487$178.06
$5.43MSell

1 of 8

JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JAZZ insiders and whales buy or sell their stock.

JAZZ Shareholders

What type of owners hold Jazz Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP50.33%30,583,176$5.18BInsider
Kkr Jp III LLC33.04%20,078,838$3.40BInsider
Michael W. Michelson30.56%18,571,250$3.15BInsider
Paul E. Raether30.54%18,557,365$3.14BInsider
Kkr Jp LLC30.54%18,557,365$3.14BInsider
Kkr Group Holdings LP16.36%9,942,946$1.68BInsider
William J. Janetschek14.12%8,577,974$1.45BInsider
Kenneth W. Okeefe10.65%6,469,439$1.10BInsider
Vanguard Group Inc9.72%5,906,945$1.00BInstitution
Bryan C. Cressey9.70%5,894,549$998.60MInsider

1 of 3

JAZZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JAZZ28.42%71.58%Net SellingNet Selling
BMRN93.36%1.73%Net SellingNet Selling
TECH97.61%2.39%Net BuyingNet Selling
RNA90.26%9.74%Net SellingNet Selling
MDGL26.01%73.99%Net BuyingNet Selling
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Ownership FAQ

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals (NASDAQ: JAZZ) is owned by 99.64% institutional shareholders, 250.92% Jazz Pharmaceuticals insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Jazz Pharmaceuticals shareholder, owning 30.58M shares representing 50.33% of the company. Kkr Group Partnership LP's Jazz Pharmaceuticals shares are currently valued at $5.18B.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.